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Introduction
We have sequenced and assembled a significant portion of the cattle tick  genome and transcriptome, 
presently at an overall 0.5X coverage. However, the coverage of the gene-rich regions of the genome are 
at ~2X coverage. This genomic resource will be hosted at Murdoch University, Perth, Western Australia as 
CattleTickBase  (http://ccg.murdoch.edu.au/index.php/Main_Page).  We  have  used  this  genomic 
information  and  additional proteomic  and  transcriptomic  information  to  guide  investigations  to  select 
antigens for evaluations in anti-cattle tick vaccine cattle stall trials.
Material and Methods
Genomic DNA from the f8 generation of the Deutsch strain of R. microplus was used to produce a 3X BAC 
library.  This  strain  was  developed  from  an  outbreak  in  south  Texas,  USA.  The  genomic  DNA  was 
processed  by  Cot  filtration  experiments  to  enrich  for  single/low-copy  DNAs  that  were  subsequently 
sequenced  by  454  methodologies  (1).  Transcriptome  information  was  obtained  by  454  Titanium 
pyrosequencing of RNA purified from various tissues and tick samples. Proteomic investigations  utilized 
two-dimensional gel electrophoretic protocols on dissected adult female ovary and gut tissues. Cattle stall 
tests  were performed in Campo Grande, Mato Grosso do Sul, Brazil using one-year-old Holstein calves 
assigned to control and treatment groups  consisting of 6 animals  per group. Each animal was  given 3 
intramuscular  injections  of  100 µg Pichia  pastoris-expressed antigen +  Montanide adjuvant spaced 2 
weeks  apart. Twenty-one days  after  the  final immunization,  each animal was  challenged with 15,000 
larvae from the Campo Grande strain of R. microplus.
Results
Based  on  proteomic,  functional genomics,  and  sequence  annotation  approaches,  we  selected 8  R. 
microplus antigens for expression in Pichia pastoris and evaluation in cattle stall tests. Preference was 
given to  proteins  that were localized in the gut  or ovary  membrane fractions  and that had sequence 
similarity to  proteins  in GenBank  annotated as  salivary-  or  salivary  gland-associated proteins. Two of 
these antigens showed greater than 70% efficacy against R. microplus when presented in 3 injections of 
100 µg P. pastoris-expressed antigen + Montanide adjuvant spaced 2 weeks apart.
Discussion and Conclusions 
Six antigens  are in various  stages  of evaluations  singly and later tests  will test the efficacy of different 
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from single- or low-copy gene families  that encode membrane-bound or membrane-associated proteins 
with critical function to the tick. The two antigens  that have shown >70%  efficacy were isolated from 
protein coding regions  from a Texas  population of R. microplus and evaluated for efficacy on Brazilian 
cattle challenged with a Brazilian strain of R. microplus. Preparations  are underway to evaluate these 
antigens  on Texas  cattle  challenged with R. microplus  ticks  isolated from outbreaks  along the border 
between Texas and Mexico.
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